It was found that either TAMs-CM or RAPA administration caused an increase in yellow and red puncta in breast cancer cells, while 3-Ma treatment or ATG5 knockdown reversed the autophagy-promoting effects of TAMs-CM (Fig. 1E). This evidence concerns the gene ATG5 and breast carcinoma.